8-125028331-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_014846.4(WASHC5):​c.3423+289G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.381 in 152,046 control chromosomes in the GnomAD database, including 12,942 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.38 ( 12942 hom., cov: 32)

Consequence

WASHC5
NM_014846.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.10

Publications

1 publications found
Variant links:
Genes affected
WASHC5 (HGNC:28984): (WASH complex subunit 5) This gene encodes a 134 kDa protein named strumpellin that is predicted to have multiple transmembrane domains and a spectrin-repeat-containing domain. This ubiquitously expressed gene has its highest expression in skeletal muscle. The protein is named for Strumpell disease; a form of hereditary spastic paraplegia (HSP). Spastic paraplegias are a diverse group of disorders in which the autosomal dominant forms are characterized by progressive, lower extremity spasticity caused by axonal degeneration in the terminal portions of the longest descending and ascending corticospinal tracts. More than 30 loci (SPG1-33) have been implicated in hereditary spastic paraplegia diseases. [provided by RefSeq, Aug 2009]
WASHC5 Gene-Disease associations (from GenCC):
  • Ritscher-Schinzel syndrome 1
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • hereditary spastic paraplegia 8
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Ritscher-Schinzel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 8-125028331-C-T is Benign according to our data. Variant chr8-125028331-C-T is described in ClinVar as [Benign]. Clinvar id is 683815.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.608 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASHC5NM_014846.4 linkc.3423+289G>A intron_variant Intron 28 of 28 ENST00000318410.12 NP_055661.3 Q12768
WASHC5NM_001330609.2 linkc.2979+289G>A intron_variant Intron 27 of 27 NP_001317538.1 E7EQI7
WASHC5XM_047422502.1 linkc.3423+289G>A intron_variant Intron 29 of 29 XP_047278458.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASHC5ENST00000318410.12 linkc.3423+289G>A intron_variant Intron 28 of 28 1 NM_014846.4 ENSP00000318016.7 Q12768
WASHC5ENST00000517845.5 linkc.2979+289G>A intron_variant Intron 26 of 26 2 ENSP00000429676.1 E7EQI7
WASHC5ENST00000519042.2 linkn.562+289G>A intron_variant Intron 2 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.380
AC:
57769
AN:
151928
Hom.:
12897
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.614
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.424
Gnomad ASJ
AF:
0.315
Gnomad EAS
AF:
0.362
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.266
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.379
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.381
AC:
57862
AN:
152046
Hom.:
12942
Cov.:
32
AF XY:
0.387
AC XY:
28744
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.615
AC:
25460
AN:
41430
American (AMR)
AF:
0.424
AC:
6479
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.315
AC:
1093
AN:
3470
East Asian (EAS)
AF:
0.360
AC:
1867
AN:
5180
South Asian (SAS)
AF:
0.454
AC:
2188
AN:
4822
European-Finnish (FIN)
AF:
0.266
AC:
2815
AN:
10576
Middle Eastern (MID)
AF:
0.503
AC:
148
AN:
294
European-Non Finnish (NFE)
AF:
0.249
AC:
16947
AN:
67964
Other (OTH)
AF:
0.386
AC:
813
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1668
3335
5003
6670
8338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.324
Hom.:
1173
Bravo
AF:
0.402
Asia WGS
AF:
0.485
AC:
1686
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.25
DANN
Benign
0.40
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7007960; hg19: chr8-126040573; API